How do peripheral arterial disease (PAD) and chronic limb ischemia (CLI) differ, and what are the recommended management strategies for each?

Peripheral Arterial Disease vs Chronic Limb Ischemia

Chronic limb-threatening ischemia (CLTI) is the most severe manifestation of peripheral artery disease (PAD), distinguished by the presence of chronic ischemic rest pain, ulcers, or gangrene lasting >2 weeks, whereas PAD encompasses the full spectrum of lower extremity atherosclerotic disease from asymptomatic to intermittent claudication to CLTI. 1, 2

Key Definitional Differences

PAD is the broader term describing atherosclerotic disease affecting lower extremity arteries, presenting across a clinical spectrum 2, 3:

• Asymptomatic disease (most common presentation)
• Intermittent claudication (IC): reproducible leg pain with walking, relieved by rest within ~10 minutes 1, 4
• CLTI: the end-stage manifestation

CLTI (formerly called "critical limb ischemia") represents inadequate resting perfusion to sustain tissue viability 1, 2:

• Chronic (>2 weeks) ischemic rest pain
• Non-healing wounds/ulcers attributable to arterial disease
• Gangrene
• The term emphasizes chronicity and distinguishes from acute limb ischemia 1

Clinical Presentation Distinctions

PAD/Intermittent Claudication

• Exertional leg symptoms (fatigue, cramping, aching) 1, 4
• Symptoms consistently induced by walking, relieved by rest 1
• Functional limitation without tissue threat 5
• ABI typically 0.4-0.9 6

CLTI

• Rest pain worse when supine, improved with leg dependency 1
• Often requires narcotic analgesia 1
• Severely disabling, disturbs sleep 1
• Quality of life worse than terminal cancer 1
• May present without pain in diabetics due to neuropathy 1
• ABI typically <0.4 (or <0.4 in non-diabetics; any diabetic with PAD is at risk) 6, 5
• Ankle pressure ≤50 mmHg or toe pressure ≤30 mmHg suggests amputation risk without revascularization 6

Patient Population Differences

CLTI patients differ significantly from IC patients 7, 8:

• Older age 8
• Higher prevalence of diabetes mellitus 6, 7, 8
• More chronic kidney disease 8
• More severe renal failure 1, 6
• Higher rates of multilevel PAD (32% vs 15%) 8
• More below-the-knee disease (47% vs 12%) 7, 8
• Less likely to receive optimal medical therapy 8

Management Strategy Differences

For PAD/Intermittent Claudication

Medical Management (First-Line) 5:

• Supervised exercise training (primary therapy) 5
• Single antiplatelet agent (clopidogrel preferred) 4
• High-intensity statin (LDL <3.1 mmol/L) 9
• Risk factor modification 5
• Smoking cessation 1, 6

Revascularization Indications 5:

• Only after 3 months of optimal medical therapy and exercise 10
• Significant disability affecting work or important activities 5
• Impaired quality of life despite conservative management 10
• Favorable anatomy with low risk/high success probability 5
• NOT indicated solely to prevent progression to CLTI 10

For CLTI

Urgent/Expedited Evaluation Required 1, 5, 10:

• Patients with CLTI should undergo expedited evaluation and treatment of amputation risk factors 1, 5
• Early recognition and referral to vascular team mandatory for limb salvage 10
• Patients at risk (diabetes, neuropathy, chronic renal failure, infection) with acute symptoms are vascular emergencies 1, 5

Immediate Management 1, 5:

• Systemic antibiotics promptly if skin ulceration with infection 1, 5
• Referral to specialized wound care providers 1, 5
• Offloading mechanical stress for ulcers 10
• Cardiovascular risk assessment if open surgery anticipated 1, 5

Revascularization Strategy 10, 11:

• Perform revascularization as soon as possible 10
• Endovascular-first approach for high surgical risk or inadequate veins 10, 11
• Vein bypass preferred for average-risk patients with advanced limb threat and complex anatomy 11
• Autologous vein preferred conduit for infra-inguinal bypass 10
• Eliminate inflow obstructions when treating downstream lesions 10

Medical Therapy 11, 12:

• Antithrombotic agents 11
• Lipid-lowering therapy 11
• Antihypertensive agents 11
• Glycemic control 11
• Exercise training NOT recommended in CLTI with wounds 10

Critical Follow-Up Differences

PAD/IC Follow-Up

• Annual assessment minimum 10
• Clinical and functional status 10
• Medication adherence 10
• Duplex ultrasound as needed 10

CLTI Follow-Up

• At least twice annually by vascular specialist due to high recurrence risk 1, 6, 5
• Regular foot inspection with shoes/socks removed 1, 6, 5
• Patients at risk (ABI <0.4 non-diabetic, or any diabetic with PAD) require regular foot inspection 6, 5
• Verbal and written self-surveillance instructions 1, 5
• Evaluation for aneurysmal disease if atheroembolization features present 1, 6, 5
• Regular assessment of clinical, hemodynamic, and functional status post-revascularization 10

Prognostic Differences

CLTI carries dramatically worse outcomes 7, 8:

• Higher 1-year mortality (4% vs 2% in IC) 8
• Higher major adverse limb events (26% vs 16% in IC) 8
• Worse primary patency rates 7
• Higher amputation rates 7
• 6-month major amputation risk without treatment 6

Common Pitfalls to Avoid

• Do not delay referral in CLTI—these are vascular emergencies requiring immediate specialist evaluation 1, 5
• Do not perform revascularization in asymptomatic PAD or solely to prevent CLTI progression 10
• Do not overlook diabetic patients with tissue loss but no pain—neuropathy masks ischemic pain 1
• Do not prescribe exercise training for CLTI patients with wounds—contraindicated 10
• Do not use ABI alone in diabetics or renal failure patients—vessels may be noncompressible (ABI ≥1.4); use toe pressures 6, 4